Age-associated defect in ADCC response to COVID-19 vaccine

  • The CITIID-NIHR BioResource COVID-19 Collaboration

Research output: Contribution to journalArticlepeer-review

Abstract

We investigated age-associated effects of SARS-CoV-2 vaccination in elderly individuals (n = 50, mean age 79) after six SARS-CoV-2 vaccine doses. While neutralization titers remained comparable across age groups, Fc-mediated effector functions declined with age. Individuals >80 demonstrated reduced antibody-dependent cellular cytotoxicity (ADCC), via a surrogate ADCC-signaling assay, correlating with diminished IgG1 binding. These findings highlight age-related impairments in Fc-mediated responses, with implications for immune protection and vaccine strategies in older populations.

Original languageEnglish
Article number132
Journalnpj Vaccines
Volume10
Issue number1
DOIs
Publication statusPublished - Dec 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

Fingerprint

Dive into the research topics of 'Age-associated defect in ADCC response to COVID-19 vaccine'. Together they form a unique fingerprint.

Cite this